Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.47 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.47 |
| ▸ | NMT2 | O60551 | 1/20 | 0.44 |
| ▸ | NMT1 | P30419 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | NPY4R | P50391 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | FURIN | P09958 | 1/20 | 0.42 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1711525 | 0.99 | CPB2 (0.49) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL1711286 | 0.99 | CPB2 (0.49) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL30512557 | 0.99 | CPB2 (0.49) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL1711530 | 0.99 | CPB2 (0.49) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL1711292 | 0.99 | CPB2 (0.49) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL29398435 | 0.96 | CPB2 (0.46) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL30496431 | 0.95 | CPB2 (0.45) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL11644225 | 0.93 | FOLH1 (0.54) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL11644217 | 0.93 | FOLH1 (0.54) | CPB2FOLH1ERAP2ERAP1LNPEP | |
| SCHEMBL31001909 | 0.92 | CPB2 (0.43) | CPB2FOLH1ERAP2ERAP1LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |